178 related articles for article (PubMed ID: 1678195)
41. Degradation of alpha and beta neo-endorphin by rat brain membrane peptidases.
Ulrich C; Hersh LB
Peptides; 1985; 6(3):475-82. PubMed ID: 2999726
[TBL] [Abstract][Full Text] [Related]
42. In vitro human plasma leucine(5)-enkephalin degradation is inhibited by a select number of drugs with the phenothiazine molecule in their chemical structure.
Mosnaim AD; Puente J; Saavedra R; Diamond S; Wolf ME
Pharmacology; 2003 Jan; 67(1):6-13. PubMed ID: 12444298
[TBL] [Abstract][Full Text] [Related]
43. Isolation of a neuropeptide-degrading endopeptidase from the leech Theromyzon tessulatum.
Laurent V; Salzet M
Eur J Biochem; 1995 Oct; 233(1):186-91. PubMed ID: 7588745
[TBL] [Abstract][Full Text] [Related]
44. Opioid peptides in rat islets of Langerhans. Immunoreactive met- and leu-enkephalins and BAM-22P.
Timmers KI; Voyles NR; King C; Wells M; Fairtile R; Recant L
Diabetes; 1986 Jan; 35(1):52-7. PubMed ID: 3510138
[TBL] [Abstract][Full Text] [Related]
45. Estimation of relative importance of three enzymes in the inactivation of [Met5]-enkephalin and [Met5]-enkephalin-Arg6 in three isolated preparations by employing the inhibitor specific for each enzyme.
Kuno Y; Oka T
Jpn J Pharmacol; 1987 Jul; 44(3):241-7. PubMed ID: 2821306
[TBL] [Abstract][Full Text] [Related]
46. Identification and characterization of aminopeptidases from Aplysia californica.
Bawab W; Querido E; Crine P; DesGroseillers L
Biochem J; 1992 Sep; 286 ( Pt 3)(Pt 3):967-75. PubMed ID: 1417757
[TBL] [Abstract][Full Text] [Related]
47. Measurement of methionine enkephalin and leucine enkephalin in rat brain regions by high-performance liquid chromatography with coulometric electrochemical detection.
Kim C; Cheng R; George SR
J Chromatogr; 1989 Sep; 494():67-76. PubMed ID: 2584346
[TBL] [Abstract][Full Text] [Related]
48. Organophosphorus anticholinesterases do not mediate analgesia through inhibition of enkephalin degradation.
Marchner H; Haraldsson S; Lundberg S
Life Sci; 1986 Apr; 38(14):1317-21. PubMed ID: 3515093
[TBL] [Abstract][Full Text] [Related]
49. The inactivation of [Met5]-enkephalin by bestatin-sensitive aminopeptidase, captopril-sensitive peptidyl dipeptidase A and thiorphan-sensitive endopeptidase-24.11 in mouse vas deferens.
Aoki K; Kajiwara M; Oka T
Jpn J Pharmacol; 1986 Feb; 40(2):297-302. PubMed ID: 3009948
[TBL] [Abstract][Full Text] [Related]
50. Differential effects on active avoidance performance and locomotor activity of two major enkephalin metabolites, tyr-gly-gly and des-tyr-[leu]enkephalin.
Weinberger SB; Martinez JL
Life Sci; 1988; 43(9):769-76. PubMed ID: 3412113
[TBL] [Abstract][Full Text] [Related]
51. Methionine-enkephalin, leucine-enkephalin methionine-enkephalin-Arg6-Phe7 and methionine-enkephalin-Arg6-Gly7-Leu8 in human pheochromocytoma.
Yoshimasa T; Nakao K; Ikeda Y; Sakamoto M; Suda M; Imura H
Life Sci; 1983; 33 Suppl 1():85-8. PubMed ID: 6664256
[TBL] [Abstract][Full Text] [Related]
52. Angiotensin converting enzyme (ACE) and neprilysin hydrolyze neuropeptides: a brief history, the beginning and follow-ups to early studies.
Skidgel RA; Erdös EG
Peptides; 2004 Mar; 25(3):521-5. PubMed ID: 15134871
[TBL] [Abstract][Full Text] [Related]
53. Conversion and inactivation of opioid peptides by rabbit brain endo-oligopeptidase A.
Camargo AC; Ribeiro MJ; Schwartz WN
Biochem Biophys Res Commun; 1985 Jul; 130(2):932-8. PubMed ID: 2992491
[TBL] [Abstract][Full Text] [Related]
54. Characterization of enkephalin-immunoreactive peptides generated by peptic digestion of rat plasma proteins.
Shen FS; Lindberg I
Endocrinology; 1988 Jun; 122(6):2905-10. PubMed ID: 3131127
[TBL] [Abstract][Full Text] [Related]
55. In vitro and in vivo effects of kelatorphan on enkephalin metabolism in rodent brain.
Waksman G; Bouboutou R; Devin J; Bourgoin S; Cesselin F; Hamon M; Fournie-Zaluski MC; Roques B
Eur J Pharmacol; 1985 Nov; 117(2):233-43. PubMed ID: 3865779
[TBL] [Abstract][Full Text] [Related]
56. Degradation of enkephalins by rat lymphocyte and purified rat natural killer cell surface aminopeptidases.
Amoscato AA; Spiess RR; Sansoni SB; Herberman RB; Chambers WH
Brain Behav Immun; 1993 Jun; 7(2):176-87. PubMed ID: 8347898
[TBL] [Abstract][Full Text] [Related]
57. Separate metabolic pathways for Leu-enkephalin and Met-enkephalin-Arg(6)-Phe(7) degradation by rat striatal synaptosomal membranes.
Benuck M; Berg MJ; Marks N
Neurochem Int; 1982; 4(5):389-96. PubMed ID: 20487892
[TBL] [Abstract][Full Text] [Related]
58. Enkephalin-containing polypeptides are potent inhibitors of enkephalin degradation.
Hui KS; Hui M; Banay-Schwartz M; DeGuzman T; Ling N; Lajtha A
Peptides; 1983; 4(5):639-46. PubMed ID: 6657512
[TBL] [Abstract][Full Text] [Related]
59. Plasma met-enkephalin and leu-enkephalin in chronic renal failure.
Zoccali C; Ciccarelli M; Mallamaci F; Maggiore Q; Lotti M; Zucchelli GC
Nephrol Dial Transplant; 1987; 1(4):219-22. PubMed ID: 3110677
[TBL] [Abstract][Full Text] [Related]
60. Effects of three peptidase inhibitors, amastatin, captopril and phosphoramidon, on the hydrolysis of [Met5]-enkephalin-Arg6-Phe7 and other opioid peptides.
Hiranuma T; Kitamura K; Taniguchi T; Kobayashi T; Tamaki R; Kanai M; Akahori K; Iwao K; Oka T
Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar; 357(3):276-82. PubMed ID: 9550299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
